-
Investment Company Myconic Capital Agrees To Buy Mindscape Ketamine & Infusions Therapy
Wednesday, March 10, 2021 - 2:17pm | 313Myconic Capital Corp. (CSE: MEDI) agreed to buy Mindscape Ketamine & Infusions Therapy PLLC for $175,000. The investment company, which previously operating as Auralite Investments Inc. and has holdings in cannabis, signed a letter of intent to acquire all shares of Mindscape for...